(Q24200225)

English

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation

scientific article

In more languages

Statements

scholarly article

0 references

Antibiotics plus colony stimulating factors versus antibiotics alone for the prevention of infections in cancer patients receiving myelosuppressive chemotherapy or haematopoetic stem cell transplantation (English)

0 references

0 references

3

0 references

6

0 references

4

0 references

5

0 references

Christine Herbst

1

object named as

Christine Herbst

0 references

author name string

Frauke Naumann-Winter

2

0 references

publication date

17 October 2012

0 references

Cochrane Database of Systematic Reviews

0 references

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Infection in cancer patients. A continuing association

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the infectious diseases working party (AGIHO) of the german society of haematology and oncology.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Prophylactic antibiotics or G-CSF for the prevention of infections and improvement of survival in cancer patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Practical methods for incorporating summary time-to-event data into meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

21 January 2018

Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008094.PUB3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD008094.PUB3

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24200225&oldid=1564123622"